Genentech Set Back by Cancer-Drug Study

jerry submitted, created time 3 months 1 day (online.wsj.com)

Genentech Inc. and OSI Pharmaceuticals Inc. said a late-stage trial showed that adding the cancer medicine Avastin to the drug Tarceva didn't prolong the lives of patients with advanced lung cancer.

Submit comment | Blog It | Email It | Keywords: Genentech lung cancer tarceva avastin cancer Cancer Drugs